Roche's Taspoglutide Setback Gives Amylin (AMLN) A Boost
Go back to Roche's Taspoglutide Setback Gives Amylin (AMLN) A Boost| Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) | Delayed: 30.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.98 | 52 Week High | $31.02 | |||
| Open | $3.30 | 52 Week Low | $8.03 | |||
| Day High | $30.98 | P/E | N/A | |||
| Day Low | $30.98 | EPS | $-4.38 | |||
| Volume | 440,704 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1170.14 +5.25 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1164.89 | 52 Week High | $88.16 | |||
| Open | $1146.15 | 52 Week Low | $67.88 | |||
| Day High | $1180.53 | P/E | 270.87 | |||
| Day Low | $1139.26 | EPS | $4.32 | |||
| Volume | 2,453,813 | |||||
